Systolic and diastolic myocardial dysfunction in cats with hypertrophic cardiomyopathy or systemic hypertension

Carolina Carlos Sampedrano1, Valérie Chetboul, Vassiliki Gouni

  • 1Unité de Cardiologie d'Alfort, Ecole Nationale Vétérinaire d'Alfort, Maisons-Alfort, France.

Insights

Tissue Doppler imaging detects similar myocardial dysfunction in cats with hypertrophic cardiomyopathy (HCM) and systemic hypertension (SHT)-induced left-ventricular hypertrophy (LVH). This dysfunction occurs even in non-hypertrophied segments, aiding disease understanding.

Area of Science:

  • Veterinary Cardiology
  • Echocardiography
  • Feline Heart Disease

Background:

  • Hypertrophic cardiomyopathy (HCM) and systemic hypertension (SHT) are common causes of left-ventricular hypertrophy (LVH) in cats.
  • Assessing LVH-associated myocardial dysfunction is crucial for understanding feline heart disease pathophysiology.

Purpose of the Study:

  • To quantify left-ventricular free-wall (LVFW) motion using tissue Doppler imaging (TDI).
  • To differentiate feline HCM from SHT-related LVH (LVH-SHT) using TDI-derived LVFW motion parameters.

Main Methods:

  • Echocardiography and 2D color TDI were performed on 108 cats (35 HCM, 17 LVH-SHT, 56 controls).
  • Analysis focused on radial and longitudinal diastolic and systolic LVFW velocities.

Main Results:

  • Both HCM and LVH-SHT groups showed similar alterations in diastolic LVFW velocities compared to controls.
  • Systolic dysfunction was observed in longitudinal motion for both hypertrophy groups, but not radial motion.
  • Diastolic dysfunction was present in non-hypertrophied segments in both HCM and LVH-SHT cats.

Conclusions:

  • LVFW motion alterations are similar in cats with HCM and LVH-SHT.
  • TDI can detect systolic and diastolic functional changes in non-hypertrophied segments.
  • These findings highlight TDI's utility in evaluating myocardial dysfunction in feline cardiac diseases.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...